Cohen Syndrome is a rare genetic disorder characterized by various physical, intellectual, and developmental challenges. It is estimated to affect approximately 1 in 100,000 to 1 in 200,000 individuals worldwide. The syndrome is caused by mutations in the COH1 gene. Common features include intellectual disability, facial abnormalities, vision problems, and low muscle tone. Additionally, individuals with Cohen Syndrome may experience delayed growth, joint hypermobility, and neutropenia. Early diagnosis and comprehensive medical care can help manage the symptoms and improve the quality of life for those affected.
Cohen Syndrome is a rare genetic disorder that affects multiple body systems. It is characterized by developmental delays, intellectual disability, facial abnormalities, and vision problems. While the exact prevalence of Cohen Syndrome is not well-established, it is considered to be an extremely rare condition.
Due to its rarity, there is limited data available regarding the number of individuals affected by Cohen Syndrome. However, it is estimated to occur in approximately 1 in every 100,000 to 1 in every 200,000 individuals worldwide. The condition has been reported in various ethnic groups and both genders.
Diagnosing Cohen Syndrome can be challenging as its symptoms can overlap with other genetic disorders. Genetic testing is typically required to confirm the diagnosis. Early intervention and management of symptoms are crucial in improving the quality of life for individuals with Cohen Syndrome.
While Cohen Syndrome is a rare disorder, it is important to raise awareness and support research efforts to better understand and assist those affected by this condition.